Evaluation of a Diagnostic Enteric Card for Management of Diarrhea
2 other identifiers
observational
436
1 country
1
Brief Summary
PATH is a member of a consortium that is developing a Diagnostic Enterics Card (DEC) which will allow clinicians to diagnose a group of diarrheagenic pathogens linked to morbidity and mortality. The pathogens detected on DEC include Salmonella, Campylobacter jejuni, Shigella species, and Escherichia coli O157:H7. This study will evaluate the performance of the assays and the platform in clinical conditions with non-expert users. It will provide important data on the performance of DEC for at least one target pathogen, an understanding of the potential impact of different sample types on device performance, and human factors associated with instrument interface in the field.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 14, 2008
CompletedFirst Posted
Study publicly available on registry
August 18, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2009
CompletedOctober 28, 2014
September 1, 2009
August 14, 2008
October 27, 2014
Conditions
Keywords
Eligibility Criteria
Patients presenting with diahrreal symptom to out-patient care facilities in Fortaleza, Brazil.
You may qualify if:
- Have 3 or greater liquid stools in the past 24 hours.
- Provide written informed consent from at least one parent in the case of children under 18 years of age.
- Provide written informed consent for those participants above 18 years of age.
- Provide assent in the case of children 10 years of age or greater.
You may not qualify if:
- Previously enrolled in the study.
- Parents are unwilling or unable to provide written informed consent.
- Report using antibiotics in the last 30 days.
- Adolescent (\<18 years old) parent of a child already enrolled in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- PATHlead
- Universidade Federal do Cearacollaborator
- University of Virginiacollaborator
- Micronics, Inc.collaborator
- Washington University Early Recognition Centercollaborator
Study Sites (1)
Hospital Infantil Albert Sabin
Fortaleza, Ceará, Brazil
Biospecimen
Stool samples are retained for future research.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2008
First Posted
August 18, 2008
Study Start
May 1, 2008
Study Completion
May 1, 2009
Last Updated
October 28, 2014
Record last verified: 2009-09